Summa~. Non-enzymatic glycosylation of tissue and haemolysate proteins has been studied in normal and diabetic rats by reduction with tritiated sodium borohydride (NaB3H4) alone or in combination with chromatography on m-aminophenylboronic acid coupled to Biogel P-6. With NaB3H4 reduction alone, there was a linear relationship between plasma glucose and tritium incorporation into haemolysate protein. However, increased non-enzymatic glycosylation of tissue protein could not be demonstrated with NaB3Hn reduction alone. Tritiated glycosylated amino acids could be selectively removed by maminophenylboronic acid immobilized on Biogel P-6, then eluted by acidification and the radioactivity in the acidic peak used to estimate non-enzymatic glycosylation. Using the combined techniques, an increase in non-enzymatic glycosylation was observed in heart, kidney and liver obtained from rats with diabetes of 18 weeks duration.
An increase in non-enzymatic glycosylation of haemoglobin and plasma proteins in diabetes has been well established and the phenomenon is used in the assessment of diabetic control [1] [2] [3] [4] [5] . It has been suggested that increased glycosylation of tissue proteins in diabetes may take place and this could be of importance in the pathogenesis of long-term diabetic complications [6, 7] . Increased glycosylation of lens, red cell membrane, nerve, glomerular basement membrane proteins and aorta have been reported [8] [9] [10] [11] [12] , but there has been no systematic study of glycosylation in other tissues. It would be of interest to compare the extent of non-enzymatic glycosylation in a variety of tissues, including those not normally affected by diabetic complications. This may provide valuable information as to the physiological significance of non-enzymatic glycosylation.
The measurement of tissue protein glycosylation is more difficult than that of glycosylated haemoglobin or plasma proteins. In this study the technique of tritiated sodium borohydride (NaB3H4) reduction alone and in combination with m-aminophenylboronic acid chromatography was used to examine non-enzymatic glycosylation of tissues obtained from rats with diabetes of 18 weeks duration. Tritium from NaB3H4 is incorporated into the ketoamine group of the l-deoxyfructosyl residue formed by the attachment of glucose to protein [13, 14] . The resultant tritiated glycosylated amino acids contain dihydroxyl groups in the coplanar cis-diol configuration and in alkaline conditions can be extracted by m-aminophenylboronic acid immobilized on a solid phase [15] . The tritiated glycosylated amino-acids are eluted by acidification and radioactivity in the acidic fraction is an index of non-enzymatic glycosylation. This procedure had been used previously for the measurement of non-enzymatic glycosylation of nerve protein, low-density lipoprotein and glycosylated aminoacids in the urine of diabetic patients [9, 15, 16] .
Materials and Methods

Induction of Diabetes and Preparation of Tissues
Inbred female Wistar rats were obtained fi'om the Australian Atomic Energy Commission, Lucas Heights, NSW. The animals weighed 230+ 5 g, and were aged 2 3 months at the beginning of lhe experiment. Diabetes was induced with streptozotocin (65 mg/kg) by IV injection in sodium phosphate buffer! (50 retool/I, pH 7.0) and confirmed by the presence of tail blood glucose levels >22mmol/l (Ames Glucometer, Elkhart, Indiana, USA) one week after injection. A group of 16 littermates was studied, of which nine were diabetic and seven se~,ed as controls. Animals were killed with Halothane 18 weeks after induction of diabetes and as much blood as possible (5-10 ml) was obtained by cardiac' puncture. Plasma glucose levels measured by a Beckman glucose analyser (glucose oxidase method) in diabetic and normal animals were 33.2 +0.6 and 8.7_+0.2 mmol/l, respectively. Kidneys, liver and heart were removed rapidly, washed in 0.15 mol/1 saline, frozen in liquid nitrogen and stored at -80 ~ Immediately before study the tissues were thawed, minced finely with a scalpel and homogenized in five volumes of phosphate buffer1, using a hand-held Teflon glass homogenizer (20strokes for heart; 10-15 strokes for other tissues). The haemoglobin concentrations in the homogenates were measured by the method of Dodge et al. [17] and found to be < 0.2% of total protein present. Haemolysate was prepared according to the method of Dodge et al. [17] . Protein concentration was measured by a fluorometric assay using Fluram (Roche, Switzerland) with bovine serum albumin as standard [18] . Protein concentration was adjusted with phosphate buffer1 to 20 mg/ml for the haemolysate and other tissues.
Reduction by NaB3H4
NaB3H4 (specific activity 228-468 mCi/mmol) was purchased from Amersham International, Amersham, Bucks, UK. Reduction was commenced by adding 200 .ul (2 mCi) of NaB3H4 in phosphate buffer1 to 1 ml of test material solution (tissue or haemolysate). The total radioactivity was estimated by immediately counting 0.5 Ixl aliquots of reaction mixtures in 10 ml of phase combining system II liquid scintillation mixture in a Wallac-LKB beta liquid scintillation counter (LKB -Produkter, Bromma, Sweden). The reaction was allowed to proceed at room temperature for 40 rain and terminated by cooling in an ice bath. The product was dialysed against phosphate buffer1 (51), with four changes over 24h; a procedure shown to remove completely NaB3H4 and free glucose. Aliquots (5 ul) were added to scintillant and counted. Results were expressed as radioactivity (DPM) incorporated per mg of protein. Control experiments showed that 3H incorporation was proportional to the amount of tissue protein (5-50 mg/ml) present in the incubation mixture. Addition of NaBH4 to a concentration of 25 retool/1 did not affect the extent of radioactivity incorporated.
Combined NaB3 H4 Reduction and m-Aminophenylboronic Acid Chromatography
After NaB3H4 reduction and dialysis, 0.8 ml of treated protein was hydrolyzed in 6 mol/1 HCI for 16 h at 108 ~ The hydrolysate was adjusted to pH 9.0 with 7 tool/1 NaOH and the amino acid concentration measured by Fluram using L-leucine as standard.
m-Aminophenylboronic acid immobilized on Biogel P-6 (Affi-Gel 601) was purchased from Bio-Rad Laboratories, Richmond, California, USA and swollen in sodium phosphate buffer2 (50mmol/l, pH 9.0). The gel was packed into a 2.0 x 1.0 cm column and equilibrated with 10 ml of phosphate buffer2. Tritiated amino-acids obtained by NaB3H4 reduction and acid hydrolysis of tissues or haemolysate (20 mg amino-acid) were applied to the column, washed with 10 ml of phosphate buffer2 and collected in one fraction. The eluting fluid was then changed to 10 ml of 0.25 tool/1 HC1 and collected. Radioactivity in each fraction was monitored by counting 200 txl in 10 rnl of phase combining system II liquid scintillation fluid. Radioactivity recovered in the acidic (second) peak is an estimate of non-enzymatic glycosylation. Results were expressed as radioactivity in the acidic peak per mg of amino-acid applied to the column.
Three diabetic and three normal rats were studied by the combined technique of NaB3H4 reduction and m-aminophenylboronic acid chromatography. These rats were selected randomly from the group of 16 previously studied by NaB3H4 reduction alone. The blood glucose and body weight of these rats were not significantly different from other animals in the experimental group.
To test for the effects of lipid on measurement of non-enzymatic glycosylation, all samples of NaB3H4-reduced tissue hydrolysates were subjected to chloroform-methanol extraction. Aliquots (1 ml) of the acid hydrolysates were mixed with 2 ml of triple distilled chloroform and 1 ml of methanol and allowed to stand overnight. Aliquots (50 ul) of the chloroform phase and of the methanol phase were counted in 10 ml of phase combining system II scintillation fluid to determine the proportion of counts incorporated into lipid during the NaB3H4 reduction. The remainder of the methanol phase was lyophilized, reconstituted in 500 gl of phosphate buffer2 and used in maminophenylboronic acid chromatography.
The effect of free glucose or haemoglobin in the vasculature on measurement of non-enzymatic glycosylation was assessed by the following experiments. Rats were anaesthetized with Ketamine (ParkeDavies, Caringbah, NSW, Australia) (140 mg/kg body weight) and laparotomy performed via a median incision. Right nephrectomy was performed and a catheter inserted into the aorta and placed just above the origin of the left renal artery. The left kidney was perfused in a non-recirculating system with 200 ml of cold (4 ~ saline (0.15 mol/1) with or without glucose (25 mmol/l). After perfusion the left kidney was excised and processed as described previously for NaB3H4 reduction and m-aminophenylboronic acid chromatography. The right kidney of each animal was used as a control. In total, two diabetic and three normal rats were studied in this manner. In addition non-enzymatic glycosylation was measured in two kidney homogenates (one normal and one diabetic) which had been dialyzed for 24 h and also in two other normal kidney homogenates augmented with glucose to reach a final concentration of 12.5 and 25 mmol/1. In each case the left kidney was treated and the right kidney served as a control.
Preparation of Glycosylated Lysine and Identification of the Acidic Peak
Poly-L-lysine (tool. wt. 60,000) was purchased from Sigma, St. Louis, Missouri, USA. Glycosylation was carried out by incubating 50 mg of the protein at 37~ for 10days in phosphate buffer~ containing 25 retool/1 of glucose. Sodium azide (1 mmol/1) was added to prevent infection. A control sample was incubated in phosphate buffer1 alone under identical conditions. After incubation the free glucose was removed by dialysis against 51 of phosphate buffer1 (four changes in 24 h). The remaining glycosylated and non-glycosylated poly-L-lysine was treated with NaB3H4 (20 mCi), dialysed and subjected to acid hydrolysis as described previously. Tritiated hydrolysate thus obtained (20 rng amino-acid) was applied to a m-aminophenylboronic acid column and eluted as before. The acidic peak obtained from chromatography of glycosylated lysine was used as reference standard.
The acidic peaks obtained from glycosylated poly-L-lysine, diabetic and normal tissues were studied by high pressure liquid chromatography using a Waters Associate Machine with a micro-NH2 Bondapak column (Waters Associate, Sydney, Australia). Elution was carried out in a step-wise manner using acetonitrile-phosphate gradient [}9]. Elution positions of several radioactive amino-acids were also determined. The same samples were also studied on a Beckman 121M amino-acid analyser using Beckman AA-15 resin packed in a column of 4.5 • 0.28 cm. Amino-acids were eluted by sodium citrate buffer (0.35 tool/l, pH 5.26) at 51 ~ and collected in I ml fractions.
Statistical Method
Results were expressed as mean _+ SEM. Linear regression was calculated by the least squares method.
Results
NaB3 H4 Reduction
Tritium incorporation into haemolysate protein was two-to threefold higher in diabetic animals. There was a good correlation between the incorporation of tritium and plasma glucose levels at the time of sacrifice (r-0.77, p < 0.002). Tritium incorporation into glycosylated poly-L-lysine (6xl06DPM/mg) was also increased in comparison with non-glycosylated poly-L-ly- Results expressed as mean _+ SEM sine (3 x 105 DPM/mg). However, when NaB3H4 reduction alone was used to study non-enzymatic glycosylation of kidney, liver and heart, no difference in the incorporation of tritium could be demonstrated between normal and diabetic tissues (Table 1 ). In general, the percentage of tritium incorporated was rather small, reaching only 0.4%/mg protein in kidney.
NaB3 H4 Reduction and m-Aminophenylboronic Acid Chromatography
Chromatography of glycosylated and non-glycosylated lysine showed that > 85% of tritiated glycosylated lysine was retained by the m-aminophenylboronic acid column and could be eluted by acidification, whereas only 5% of the tritiated non-glycosylated lysine was retained. In all samples studied a large peak of radioactivity could be eluted with phosphate buffer2 but only a relatively small fraction of the radioactivity was retained by the column and eluted following acidification. Total radioactivity recovered (alkaline peak+ acidic peak) was 96.9 -+-2.7% for all samples. The acidic peak contained tritiated glycosylated amino-acids and when expressed as radioactivity/rag of amino acid applied to column it was higher in all diabetic tissues or haemolysates studied ( Table 2) .
Identification of Radioactivity in the Acidic Peak
When the acidic peaks of hydrolysates from all diabetic and normal tissues were studied by either high pressure liquid chromatography or amino-acid column chroma- 
Chloroform-Methanol Extraction Experiments
In all samples of acid hydrolysate subjected to chloroform-methanol extraction < 1% of radioactivity was recovered in the chloroform phase and there was no difference between the diabetic and normal samples. When tritium-labelled amino acids in the methanol phase were applied to the m-aminophenylboronic acid column, a higher amount of radioactivity was recovered in the acidic peak of diabetic samples.
Pelfusion and Dialysis Experiments
The radioactivity in the acidic peak was reduced by 10% when the left kidney was perfused before measurement of non-enzymatic glycosylation. This reduction occurred in both normal and diabetic kidney and was not affected by addition of glucose (25 mmol/1) to the perfusate. Similar reduction could be observed if diabetic or normal kidney homogenate was dialysed for 24 h before NaB3H4 treatment. However, even after perfusion or dialysis, the radioactivity recovered in the acidic peak of diabetic kidneys was two-to threefold higher than that obtained from normal kidney. In agreement with the perfusion experiments, addition of glucose to kidney homogenates to reach a final concentration of 12.5 or 25 mmol/1 had no effect on the recovery of radioactivity in the acidic peak.
Discussion
The measurement of glycosylated haemoglobin or glycosylated plasma proteins is now generally available for the assessment of metabolic control in diabetes [3] [4] [5] . It has been suggested that the process of non-enzymatic glycosylation of protein is a more generalized phenomenon affecting body tissues as well as circulating proteins [6, 7, 16] . Investigations in this important area have been limited by the technical difficulty of measuring tissue glycosylation [15] . The popular method of NaB3H4 reduction is not specific for the ketoamine bond of the glycosylation adduct. Depending on the conditions of the reduction, fatty acid ester can be reduced to its alcohol and peptide bonds can be converted to amino alcohols [20, 21] . Thus, in the case of tissue proteins it was necessary to extract selectively only those residues with tritium specifically bound to the ketoamine bond of the non-enzymatic glycosylation reaction. This was achieved using a combination of NaB3H4 reduction and m-aminophenylboronic acid chromatography. This technique had been used by Brownlee et al. to study levels of glycosylated peptides and amino acids in urine and peripheral nerves [9, 22] and by Witztum et al. [16] to study glycosylation of low density lipoprotein.
m-Aminophenylboronic acid reacts in alkaline conditions with residues possessing hydroxyl groups in the coplanar cis-diol configuration and will thus selectively remove glycosylated amino acids from other substances present in the incubation mixture. The immobilized tritiated glycosylated amino acids are recovered and quantitated after acidification. The m-aminophenylboronic acid column also immobilizes free glucose, ATP and ribonucleic acid [23, 24] . However these substances are either removed by the prior extensive dialysis of the samples or not reduced by NaB3H4, thus they do not interfere with the estimation. Amino acids glycosylated by enzymatic mechanisms are also not reducible by NaB3H4 and would not interfere in this study.
Using the combined technique of NaB3H4 reduction and m-aminophenylboronic acid chromatography a consistent increase in non-enzymatic glycosylation was demonstrated in diabetic tissues when measured in terms of radioactivity present in the second peak. The finding of similar results in the chloroform-methanol treated samples ruled out the possibility that interference by lipid was responsible for the observed increase. As NaB3H4 was used only in tracer quantity in this study the increase in non-enzymatic glycosylation could not be reported in absolute molar terms. The difference of diabetic and normal tissues was not abolished by perfusion or dialysis of the samples before NaB3H4 reduction and could not be mimicked by addition of glucose to normal kidney. Thus, it is unlikely that free glucose or haemoglobin in the vasculature can account for the results observed. In accord with the findings of Brownlee et al. [15] , and Witztum et al. [16] we also found nonenzymatic glycosylation to occur by attachment to lysine.
The significance of increased tissue non-enzymatic glycosylation in diabetes remains to be resolved. Glycosylation of haemoglobin has been shown to increase its oxygen affinity and may be important in causing tissue hypoxia and diabetic complications [25] . Increased glycosylation of red cell membrane may be important in causing changes in viscosity of the red cell membrane known to exist in diabetes [26] . The significance of nonenzymatic glycosylation on the stability of collagen fibres was studied previously [27, 28] . Increased non-enzymatic glycosylation of low density lipoprotein may be important in the metabolism of this protein and in atherosclerosis [16] . Our preliminary observation that tissue glycosylation was increased in most tissues would suggest that glycosylation is a general phenomenon. The smaller increase of non-enzymatic glycosylation of liver may account for the relative sparing of this organ from diabetic complications. It is possible that a selective increase in glycosylation of some tissue components may be more important in changing the functional properties of proteins. Further studies need to be carried out to investigate the dynamics of tissue glycosylation, the reversibility by insulin therapy and to identify functional changes in proteins induced by tissue glycosylation.
